Family Care Center Study Finds TMS Boosts Cognition in Treatment-Resistant Depression — Family Care Center, LLC

Event summary

Family Care Center published a peer-reviewed study on June 11, 2026, showing TMS improves processing speed and self-reported cognitive function in treatment-resistant depression patients.
The study, the first of its kind, assessed neurocognitive changes after a full 30-session TMS course.
Significant improvements were observed in processing speed (p = .006) and self-reported executive functioning (p = .008).
The research was conducted by Family Care Center's TMS Center of Excellence and published in the journal Transcranial Magnetic Stimulation.

The big picture

This study expands the understanding of TMS beyond mood improvement, highlighting its potential to restore cognitive function in depression. Family Care Center, backed by Revelstoke Capital Partners, is positioning itself as a leader in innovative mental health treatments. The findings could reshape how cognitive outcomes are measured in depression treatment, potentially influencing clinical guidelines and patient expectations.

What we're watching

Clinical Validation: Whether these findings will accelerate TMS adoption for cognitive benefits beyond mood improvement.
Research Expansion: The pace at which follow-up studies will investigate specific areas of executive function.
Market Differentiation: How Family Care Center leverages this research to strengthen its position in the TMS treatment space.